Peptidylarginine deiminase type 4, anticitrullinated peptide antibodies, and rheumatoid arthritis

This publication has 27 references indexed in Scilit:

• Citrullinated proteins in rheumatoid arthritis
  Frontiers in Bioscience-Landmark, 2005
• Structural basis for Ca2+-induced activation of human PAD4
  Nature Structural & Molecular Biology, 2004
• Functional haplotypes of PADI4, encoding citrullinating enzyme peptidylarginine deiminase 4, are associated with rheumatoid arthritis
  Nature Genetics, 2003
• THE CENTRAL EFFECTORS OF CELL DEATH IN THE IMMUNE SYSTEM
  Annual Review of Immunology, 1999
• Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies.
  Journal of Clinical Investigation, 1998
• Detection of Deiminated Proteins in Rat Skin: Probing with a Monospecific Antibody After Modification of Citrulline Residues
  Journal of Investigative Dermatology, 1995
• The cytokeratin filament-aggregating protein filaggrin is the target of the so-called "antikeratin antibodies," autoantibodies specific for rheumatoid arthritis.
  Journal of Clinical Investigation, 1993
• High diagnostic value in rheumatoid arthritis of antibodies to the stratum corneum of rat oesophagus epithelium, so-called ‘antikeratin antibodies’.
  Annals of the Rheumatic Diseases, 1989
• Anti-keratin antibodies in rheumatoid arthritis.
  BMJ, 1979
• The antiperinuclear factor. 1. The diagnostic significance of the antiperinuclear factor for rheumatoid arthritis.
  Annals of the Rheumatic Diseases, 1979